Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Eukaryotic Gene Expression
IF: 1.841 5-Year IF: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Print: 1045-4403
ISSN Online: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v21.i2.20
pages 115-129

Signaling Pathways in Pancreatic Cancer

Murray Korc
Dartmouth Medical School
Meir Preis
Departments of Medicine, and Pharmacology and Toxicology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, Dartmouth Medical School, Hanover, New Hampshire


Pancreatic ductal adenocarcinoma (PDAC) is a deadly malignancy characterized by a plethora of molecular alterations that include major and minor driving mutations, the presence of intense desmoplasia exhibiting numerous proliferating pancreatic stellate cells (PSC) and cancer-associated fibroblasts that produce fibronectin and collagens, and foci of inflammatory cells that produce mitogenic cytokines. This review will focus on signaling by tyrosine kinase receptors, and the role of transforming growth factor beta in this malignancy is described briefly. Potential for therapeutic interventions will be discussed in relation to specific pathways.

Articles with similar content:

Aberrant Receptor Signaling and Trafficking as Mechanisms in Oncogenesis
Critical Reviews™ in Oncogenesis, Vol.13, 2007, issue 1
Tor Erik Rusten, Kaisa Haglund, Harald Stenmark
Neuroendocrine Cells in Prostate Cancer
Critical Reviews™ in Eukaryotic Gene Expression, Vol.14, 2004, issue 4
Sarah J. Parsons, George P. Amorino
KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma
Journal of Environmental Pathology, Toxicology and Oncology, Vol.36, 2017, issue 3
S. Niranjali Devaraj, Venugopal Vinod Prabhu
Cell Signaling Pathways Related to Epithelial Mesenchymal Transition in Cancer Metastasis
Critical Reviews™ in Oncogenesis, Vol.24, 2019, issue 1
Sevinc Inan, Mürvet Hayran
Oncogene-lnitiated Aberrant Signaling Engenders the Metastatic Phenotype: Synergistic Transcription Factor Interactions are Targets for Cancer Therapy
Critical Reviews™ in Oncogenesis, Vol.7, 1996, issue 3-4
David T. Denhardt